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Introduction: The production of recombinant proteins is essential for the characterization and functional 
study of proteins from Plasmodium falciparum. However, the proteins of P. falciparum are among the 
most challenging to express, and when expression is achieved, the recombinant proteins usually fold 
incorrectly and lead to the formation of inclusion bodies.
Objective: To obtain and purify four recombinant proteins and to use them as antigens to produce 
polyclonal antibodies. The production efficiency and solubility were evaluated as the proteins were 
expressed in two genetically modified strains of Escherichia coli to favor the production of heterologous 
proteins (BL21-CodonPlus (DE3)-RIL and BL21-pG-KJE8).
Materials and methods: The four recombinant P. falciparum proteins corresponding to partial 
sequences of PfMyoA (Myosin A) and PfGAP50 (gliding associated protein 50), and the complete 
sequences of PfMTIP (myosin tail interacting protein) and PfGAP45 (gliding associated protein 45), 
were produced as glutathione S-transferase-fusion proteins, purified and used for immunizing mice.
Results: The protein expression was much more efficient in BL21-CodonPlus, the strain that contains 
tRNAs that are rare in wild-type E. coli, compared to the expression in BL21-pG-KJE8. In spite of 
the fact that BL21-pG-KJE8 overexpresses chaperones, this strain did not minimize the formation of 
inclusion bodies. 
Conclusion: The use of genetically modified strains of E. coli was essential to achieve high expression 
levels of the four evaluated P. falciparum proteins and lead to improved solubility of two of them. The 
approach used here allowed us to obtain and purify four P. falciparum proteins in enough quantity to 
produce polyclonal antibodies in mice, and a fair amount of two pure and soluble recombinant proteins 
for future assays.
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Producción de proteínas recombinantes de Plasmodium falciparum en Escherichia coli
Introducción. La producción de proteínas recombinantes es fundamental para el estudio funcional de 
las proteínas de Plasmodium falciparum. Sin embargo, las proteínas recombinantes de P. falciparum 
están entre las más difíciles de expresar y, cuando lo hacen, usualmente se agregan dentro de cuerpos 
de inclusión insolubles.
Objetivo. Evaluar la producción de cuatro proteínas de P. falciparum usando como sistema de 
expresión dos cepas de Escherichia coli genéticamente modificadas para favorecer la producción 
de proteínas heterólogas y establecer una reserva de proteínas recombinantes puras y solubles, y 
producir anticuerpos policlonales a partir de ellas.
Materiales y métodos. Las proteínas recombinantes, las cuales correspondían a secuencias parciales 
de PfMyoA (Miosina-A) y PfGAP50 (proteína-asociada a glideosoma de 50 kDa) y a las secuencias 
completas de PfMTIP (proteína de interacción con miosina-A) y PfGAP45 (proteína asociada a 
glideosoma de 45 kDa), fueron expresadas como proteínas de fusión con la glutatión S-transferasa y 
luego purificadas y usadas para producir anticuerpos policlonales en ratón.
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Resultados. La expresión de las proteínas recombinantes fue mucho más eficiente en la cepa BL21-
CodonPlus (la cual expresa tRNAs escasos en las bacterias silvestres), que en la cepa BL21-pG-KJE8. 
Por el contrario, aunque la cepa BL21-pG-KJE sobreexpresa chaperonas, no redujo la formación de 
cuerpos de inclusión. 
Conclusión. El uso de cepas de E. coli genéticamente modificadas fue fundamental para alcanzar 
altos niveles de expresión de las cuatro proteínas recombinantes evaluadas y permitió obtener dos 
de ellas en forma soluble. La estrategia utilizada permitió expresar cuatro proteínas recombinantes 
de P. falciparum en cantidad suficiente para inmunizar ratones y producir anticuerpos policlonales y, 
además, conservar proteína pura y soluble de dos de ellas para ensayos futuros.
Palabras clave: Plasmodium falciparum, proteínas recombinantes, Escherichia coli.
doi: http://dx.doi.org/10.7705/biomedica.v36i3.3011
Malaria is the most important parasitic infection 
worldwide and one of the greatest public health 
challenges in developing countries. Of the five 
species of Plasmodium that infect humans, P. 
falciparum is the most lethal and causes 198 
million new cases each year and nearly 600,000 
deaths (1). Despite the reduction in the incidence 
and mortality of malaria over the past decade, 
there is a global emergence and gradual spread of 
antimalarial drug resistance, which has prompted 
significant efforts to determine the molecular 
mechanisms governing the biology of the parasite, 
either to counter this resistance or to propose 
alternative therapeutic targets.
Plasmodium spp. is an obligate intracellular para-
site whose survival and proliferation depends on 
its ability to invade the host cell. Apicomplexan 
parasites actively enter host cells making use of a 
unique form of motility referred to as gliding, powered 
by an actomyosin-motor immersed into a protein 
complex termed the glideosome (2,3). Since the 
proteins in this complex are highly conserved and 
specific to all Apicomplexa (4), the glideosome has 
enormous potential as chemotherapeutic target. 
However, the characterization and functional study 
of proteins from extracts of parasites in culture is 
difficult because it is impossible to obtain them in 
pure form and in sufficient quantities. Thus, many 
of the current functional studies rely on recombinant 
protein production in heterologous expression 
systems, amongst which Escherichia coli is the 
most widely used. Its popularity is primarily a 
result of the abundant knowledge of the biology 
and biochemistry of this bacterium, the facility 
of its genetic manipulation and the low cost of 
culture maintenance (5). Despite these advantages, 
the expression of the recombinant proteins of 
Plasmodium is hampered by the high A/T content 
in its genome (80%) (6) and the dissimilar codon 
usage between these two organisms (7), with 
both issues leading to the production of truncated 
proteins or inefficient synthesis (8). Moreover, the 
recombinant proteins can fold incorrectly and lead 
to the formation of inclusion bodies (9), which 
hinder their purification.
The aim of this work was to assess two genetically 
modified strains of E. coli, BL21-CodonPlus (DE3)-
RIL and BL21-pG-KJE8, on the expression of 
four P. falciparum glideosome proteins: Myosin 
A (PfMyoA), the myosin tail interacting protein 
(MTIP), the gliding-associated protein GAP45 and 
the gliding-associated protein GAP50. The first 
strain overexpresses four tRNAs that are typically 
rare in wild-type strains of E. coli, and the second 
strain overexpresses five chaperones (dnaK, dnaJ, 
grpE, groEL, and groES) that promote the correct 
folding of proteins. The recombinant proteins were 
obtained as glutathione S-transferase (GST) fusion 
proteins from the partial sequences of the PfmyoA 
and gap50 genes and complete sequences of the 
genes mtip and gap45. 
The results showed that the expression of the four 
recombinant proteins of P. falciparum was much 
more efficient in strains containing tRNAs normally 
scarce in wild-type strains of E. coli, than in strains 
that have elevated levels of chaperone proteins. 
Furthermore, the use of the latter did not diminish 
the formation of insoluble protein aggregates. Finally, 
the purified recombinant proteins were produced 
in suitable quantities for immunizing mice and 
generating antibodies, which recognized the four 
proteins of interest in P. falciparum protein extracts.
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Materials and methods
Bioinformatics
The A/T content of the sequences coding for the 
recombinant proteins was assessed with the GC 
Content Calculator (http://www.biologicscorp.com/
tools/GCContent). The theoretical molecular weight 
and isoelectric point (pI) of each recombinant 
protein were calculated with the ExPASy compute 
pI/Mw tool (http://web.expasy.org/compute_pi/), and 
the charge and number of acidic aminoacids of the 
proteins were determined using PEPSTATS (http://
www.ebi.ac.uk/Tools/seqstats/emboss_pepstats/). 
Finally, as codons are unevenly used in different 
organisms, the codon usage bias between E. coli 
and P. falciparum was examined using the Codon 
Usage Database at http://www.kazusa.or.jp/codon/. 
To assess preferences for particular synonymous 
codons, the number and frequency of each codon 
in the recombinant sequences were calculated 
using Sequence Manipulation Suite (SMS) (http://
www.bioinformatics.org/sms2/reference.html).
Cloning of genes
Based on the sequences of PfmyoA, mtip, gap45 
and gap50 (PlasmoDB ID: PF3D7_1342600, 
PF3D7_1246400, PF3D7_1222700 and PF3D7_ 
0918000, respectively), gene-specific primers were 
designed as described in table 1. Each fragment 
was amplified from genomic DNA of P. falciparum 
(3D7 strain) that was extracted by proteinase K 
lysis, phenol chloroform treatment and subsequent 
dialysis against TE buffer (10). The polymerase 
chain reaction (PCR) conditions were as follows: 
200 µM dNTPs, 1 µM primers, 0.625 U Pfu DNA 
polymerase (Thermo scientific) and 1.5 mM 
MgSO4. The amplification program included an 
initial denaturation cycle of 94°C x 5 min; 35 cycles 
of 94°C x 30 s, 50°C x 30 s, and 72°C x 1 min; and a 
final extension of 72°C x 7 min. The amplicons were 
cloned into the vector pGEM-T easy (Promega) 
using the manufacturer’s recommendations.
Subcloning into pGEX-4T2 
The cloned fragments in pGEM-T easy were 
released by digestion with the enzymes BamHI 
and NotI and ligated into the expression vector 
pGEX-4T2 (Amersham Pharmacia Biotech) in the 
presence of T4 DNA ligase (Promega) following 
the manufacturer’s recommendations. The ligation 
products were transformed into TOP10 bacteria 
(Invitrogen™) by heat shock. The colonies were 
confirmed by PCR and the presence of the fragment 
of interest was verified by sequencing.
Expression of recombinant proteins 
The TOP10 (Invitrogen™), BL21-CodonPlus (DE3)-
RIL (Agilent) and BL21-pG-KJE8 (Takara Bio Inc) 
strains were transformed with the recombinant 
plasmids. For expression assays, a positive colony 
for each construct in each strain was grown in LB 
medium that was supplemented with 100 µg/ml 
ampicillin and 50 µg/ml chloramphenicol overnight 
at 37° C with constant stirring at 200 rpm. The 
following day, each culture was diluted with fresh 
medium, and for the BL21-pG-KJE8 system, the 
medium was supplemented with 1 mg/ml arabinose 
and 10 ng/ml tetracycline (chaperone expression-
inducing agents). The cultures were incubated until 
they reached an optical density (OD600) between 
0.6 and 0.8, time at which isopropyl thio-beta-
galactopyranoside (IPTG, 0.1 mM) was added, 
and growth was allowed for 16 h at 37° C. 
Aliquots of 1 ml were collected just before induction 
(time 0) and at 2, 4, and 16 h after induction. 
These aliquots were centrifuged at 1,000 x g for 
5 min; the pellet was solubilized in 1X loading 
buffer for sodium dodecyl sulfate polyacrylamide 
Table 1. Sequences of primers
Gene size (bp) Sequence 5’- 3’ Amplicon size Position on gene
PfmyoA
2841 pb
F: GGATCCGCAAATCCAGTTCTTGAAGCT 766 bp 1062-1812
R: GCGGCCGCTAAAATACTTCAAAACCAAAAATATC
mtip
615 pb
F: GGATCCATGAAACAAGAATGCAATGTA 629 bp Complete gene
R: GCGGCCGCTTATTGTAATATATCTTCACAGA
gap45
615 pb
F: GGATCCATGGGAAATAAATGTTCAAGAAG 629 bp Complete gene
R: GCGGCCGCTTAGCTCAATAAAGGTGTATCGG
gap50
1191 bp
F: GGATCCATGCAACTACGCTTTGCGTCTTTG 470 bp 75-525
R: GCGGCCGCTTAAGCAGCTAAATCTTTATGGCC
The primers for amplifying the mtip and gap45 genes amplify the complete sequence of the gene, whereas those for PfmyoA and gap50 amplify a 
partial sequence. bp: base pairs. F: primer forward. R: primer reverse. GGATCC: restriction site for BamHI. GCGGCCGC: restriction site for NotI. 
TTA CTA: stop codons 
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gel electrophoresis (SDS-PAGE) and the proteins 
were denatured at 95° C for 5 min. The resulting 
extract was run on 10% denaturing acrylamide 
gels, and the recombinant proteins were detected 
by Coomassie blue staining and/or western blotting 
(WB). The expression from the pGEX-4T2 vector 
results in GST fusion proteins with the GST tag 
(26 kDa) at the amino terminus and the protein 
of interest at the carboxyl terminus; thus, a poly-
clonal anti-GST antibody (Sigma) was used as the 
primary antibody to detect recombinants in WB. A 
signal amplification system that involved the use of 
a secondary anti-rabbit IgG antibody conjugated to 
biotin (Sigma) and alkaline phosphatase enzyme 
conjugated to streptavidin (Pierce TM) was used.
Evaluation of the solubility of the recombinant 
proteins 
The bacterial culture was centrifuged at 1,000 x g 
and the pellet was re-suspended in five volumes 
of buffer R (50 mM NaCl, 50 mM Tris HCl pH 7.5 
and 5% glycerol), lysozyme (1 mg/ml) and 1:200 
protease inhibitor cocktail (Sigma). Five cycles of 
freezing and thawing (liquid nitrogen x 45 s, water 
bath at 37° C x 2 min) were performed, and the 
suspension was then centrifuged at 15,000 x g 
for 15 min to separate the supernatant from the 
particulate fraction. The presence of the protein of 
interest in both fractions was monitored by SDS-
PAGE and WB to determine its solubility.
Effect of temperature on the recovery of soluble 
proteins
In certain cases, temperature decrease may reduce 
the formation of protein aggregates and thus im-
prove the solubility of the recombinant proteins (11). 
Therefore, the protocol previously described for 
the expression of proteins in E. coli BL21-pG-KJE8 
was followed with the culture maintained at 30° C.
Purification of recombinant proteins
The soluble recombinant proteins were purified by 
affinity chromatography with glutathione-agarose 
resin (Thermo Scientific) from 1 L of the bacterial 
culture. The purification was performed in a batch 
with 300 µl of the resin bed per 6 ml extract. Binding 
was allowed for 30 min at 4° C with gentle shaking; 
the mixture was then centrifuged at 1,000 x g for 2 
min and the supernatant was saved. The resin was 
washed 10 times each with 10 volumes of wash 
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl) or 
until the absorbance of the wash solution at 280 
nm was at or below 0.010. The recombinant protein 
was eluted with 300 µl elution buffer (50 mM Tris-
HCl pH 8.0, 150 mM NaCl and 10 mM reduced 
glutathione). The resulting eluates were analyzed 
by SDS-PAGE and stored at -70° C.
The insoluble recombinant proteins were purified 
from the particulate fraction as follows: One gram 
of pellet was homogenized in wash buffer (100 
mM Tris-HCl pH 7, 5 mM EDTA, 5 mM DTT, 2 M 
urea, 2% triton X-100) and centrifuged at 22,000 x 
g for 30 min at 4° C. This procedure was repeated 
twice, and the resulting inclusion bodies were then 
re-suspended in wash buffer without urea or Triton 
and centrifuged two times as mentioned above; 
0.5 ml of extraction buffer (50 mM Tris-HCl pH 
7, 5 mM EDTA, 5 mM DTT, 8 M guanidine-HCl), 
were added to the pellet and the suspension was 
then homogenized and centrifuged at 17,000 x 
g for 1 h at 4° C. The supernatant was dialyzed 
against 1 L of dialysis buffer (150 mM NaCl and 
50 mM Tris-HCl pH 8.0) with two buffer changes. 
The resulting suspension after dialysis was run 
under denaturing conditions on a preparative gel. 
The region of the gel containing each recombinant 
protein was excised, triturated, and incubated with 
four volumes of ultrapure water at 37° C for 4 h 
(12). The purity and concentration of the protein in 
the eluate were analyzed by SDS-PAGE and WB.
Production of polyclonal antibodies
Each of the purified recombinant proteins was 
inoculated intraperitoneally into four Balb/c mice 
of 5-6 weeks of age. The immunization schedule 
consisted of three injections on days 1, 14 and 
35, the first one with 100 µg of protein in Freund’s 
complete adjuvant and two boosts with 50 µg of 
antigen in incomplete adjuvant. The final bleeding 
was done on day 42 (13). Then, the four recom-
binant proteins (50-250 ng/lane) and P. falciparum 
protein extracts (Strain 3D7, 50-100 µg/lane) were 
separated by SDS-PAGE, transferred onto PVDF 
or nitrocellulose membranes and immunoblotted 
with the produced antibodies. The anti-MTIP, anti-
GAP50 and anti-GAP45 sera were used at dilutions 
of 1:500, while the anti-MyoA serum was used at 
a dilution of 1:5000. The secondary antibody used 
was biotin goat-anti mouse antibody (Dako) at 
a dilution of 1:2000 or 1:5000, respectively, and 
streptavidin conjugated to alkaline phosphatase 
(1:3000) (Promega) or horseradish peroxidase 
(1:10000) enzymes (Vector).
Ethics
This study was approved by the Ethics Committees 
of the Colombian Instituto Nacional de Salud 
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(approval 9, October 7th, 2010) and of the Facultad 
de Ciencias of the Universidad Nacional de 
Colombia (approval 5, October 11th, 2010).
Results
Bioinformatics
The A/T content of the sequences coding for the 
recombinant proteins was about 65% in all the 
cases. The theoretical molecular weight and pI of 
the four recombinants: GST-PfMyoA, GST-PfMTIP, 
GST-PfGAP45 and GST-PfGAP50, were 54.6 
kDa/5.67, 49.8 kDa/4.71, 49.9 kDa/4.83 and 43.6 
kDa/6.33, respectively. The PEPSTATS tool found 
70, 77, 90 and 51 acidic amino acids equivalent to 
15%, 18%, 21% and 13% of the total amino acids 
in the named proteins. As stated above, BL21-
CodonPlus (DE3)-RIL strain overexpresses four 
tRNAs that are typically rare in wild-type strains of 
E. coli; then, the Codon Usage Database was used 
to get the frequency of use of AGA, AGG, AUA and 
CUA codons in E. coli and P. falciparum. The relative 
abundance of these codons in the expressed 
sequences was also calculated (table 2).
Effect of host strain on the production of 
recombinant proteins
This study evaluated the expression of four pro-
teins from P. falciparum in three different strains 
of E. coli: TOP10, BL21-CodonPlus (DE3)-RIL 
(hereinafter called CodonPlus), and BL21-pG-KJE8 
(hereinafter called pG-KJE8). The IPTG-induced 
expression of each protein was evaluated by SDS-
PAGE and WB with an anti-GST antibody; GST-
PfMyoA, GST-PfMTIP, GST-PfGAP45 and GST-
PfGAP50 proteins were detected as bands of ∼52 
kDa, ∼55 kDa, ∼60 kDa and ∼43 kDa, respectively. 
The recombinant GST-PfGAP45 had the same 
molecular weight (∼60 kDa) as one of the molecular 
chaperones (groEL) expressed in the pG-KJE8 
strain, resulting in bands overlapping; thus, at time 
zero, a band was observed that corresponded to 
the chaperone groEL. Expression of this recom-
binant was confirmed by WB that showed a weak 
expression in this strain. In contrast to the other 
three proteins, GST-PfMTIP was not successfully 
expressed in E. coli pG-KJE8 (figure 1).
Regarding the incubation time for the CodonPlus 
system, GST-PfGAP45 was expressed from 2 h 
post incubation; however, at 16 h a decreased 
signal was observed, which suggests proteolytic 
degradation. GST-PfMTIP was expressed quite 
well from 2 h after incubation and increased 
until 16 h. For GST-PfGAP50, expression was 
significantly higher compared to that of the other 
two recombinant proteins, and it was produced in 
large amounts beginning at 2 h after incubation 
and continuing until 16 h (figure 1). The expression 
of GST-PfMyoA did not increase in the CodonPlus 
strain and was almost undetectable by Coomassie 
blue staining; conversely, in the pG-KJE8 strain, 
protein synthesis was evident between 2 and 4 h 
of incubation (figure 1).
Effect of host strain on the solubility of the 
recombinant proteins
Once the optimal conditions for the production of 
each recombinant protein had been established, 
solubility was assessed. For this test, protein 
extracts were prepared under non-denaturing 
conditions, and the presence of the protein of 
interest in both the cytosolic extract and pellet 
was evaluated. GST-PfGAP45 and GST-PfMTIP 
Table 2. Frequency of AGA, AGG, AUA and CUA codons in the four recombinant proteins
Frequency per 1000 AA How many times this AA/How many times this codon
Percentage of this codon in the expressed sequence
AA Codon In
E. coli
In
P. fal.
PfMyoA
250 AA
PfMTIP
204 AA
PfGAP45
204 AA
PfGAP50
150 AA
Arg AGA 2.4 15.9 11/7
2.8%
3/1
0.5%
9/6
2.9%
3/2
1.3%
AGG 2.1 4.3 11/2
0.8%
3/1
0.5%
9/0
0%
3/0
0%
Ile AUA 5.0 50 21/11
4.4%
13/6
2.9%
10/5
2.5%
9/5
3.3%
Leu CUA 3.4 6 15/0
0%
18/0
0%
9/1
0.5%
24/0
0%
The AGA and AGG codons for arginine (Arg), AUA codon for isoleucine (Ile) and CUA codon for leucine (Leu), are rarely used in E. coli. The table 
shows how many times Arg, Ile and Leu are present in the expressed sequence, how many of these arginines, isoleucines and leucines are coded by 
AGA, AGG, AUA or CUA, and the percentage of each one of these codons (with one hundred percent considered to be the number of amino acids of 
the expressed sequence). Percentages ≥3% are highlighted in bold. The codon usage frequencies were taken from http://www.kazusa.or.jp/codon/. 
AA: Amino acid. P. fal: Plasmodium falciparum 
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were found in both the cytosolic fraction and pellet, 
whereas GST-PfGAP50 and GST-PfMyoA were 
found in the pellet (figure 2). These two proteins 
were only soluble in the presence of strong 
chaotropic agents such as 8 M guanidine, which 
indicated that insoluble protein aggregates or 
inclusion bodies (IB) had formed. No differences 
in solubility were observed between the host strain 
that co-expressed the chaperones and strains that 
only had basal levels of these proteins.
Top 10
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Figure 1. SDS-PAGE of the whole bacterial extracts from each expression system.
The production of GST-PfGAP45, GST-PfMTIP, GST-PfGAP50 and GST-PfMyoA proteins was monitored 2, 4, and 16 h after IPTG-
induced expression. The expression was evaluated in three different strains of E. coli: TOP10, BL21-CodonPlus (DE3)-RIL and 
BL21-pG-KJE8. In the upper part of the figure, the strain and induction time (h) are specified. For GST-PfGAP45, the WB using an 
anti-GST antibody is found below the gel and corresponds exactly to the electrophoresis lanes. MW: Molecular weight marker in kDa 
(Sigma). C: Control cells expressing only the GST tag (26 kDa). The black arrow indicates the protein of interest.
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Effect of temperature on the solubility of 
recombinant proteins expressed in the strain 
pG-KJE8
Because the activity of certain chaperones of E. 
coli is increased at temperatures of approximately 
30° C, and temperature reduction at the time of 
induction has been used favorably to improve the 
solubility of the recombinant proteins (11,14,15), 
an expression assay was conducted by incu-
bating at 30° C proteins GST-PfMyoA and GST-
PfGAP50 producing pG-KJE8 clones. Despite this 
modification, no increase in the solubility of the two 
proteins was observed (figure 3).
Purification of recombinant proteins 
The culture was scaled up to 1 L to obtain sufficient 
raw material to begin the purification process. The 
soluble GST-PfMTIP protein was purified by affinity 
chromatography (Pierce TM Glutathione Agarose), 
and although other lower-weight bands were found 
using SDS-PAGE, GST-PfMTIP was always found 
in greater amounts than the others (figure 4). The 
bands of different molecular weights were most 
likely degraded or truncated proteins whose GST tag 
at the amino terminus allowed their co-purification 
by affinity chromatography and recognition by the 
anti-GST antibody. Furthermore, although GST-
GST-PfGAP45 GST-PfMTIP GST-PfGAP50 GST-PfMyoA
Codon
M
200
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97
66
45
29
200
116
97
66
45
29
200
116
97
66
45
29
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116
97
66
45
29
S SP M S PP M S SP P M S SP P
CodonpG-KJE8 Codon pG-KJE8 Codon pG-KJE8
Figure 2. SDS-PAGE of soluble and insoluble fractions of Escherichia coli cultures expressing each one of the recombinant proteins.
Bacteria were grown at 37°C and then harvested and disrupted 2 hours post induction (hpi) for GST-PfMyoA and GST-PfGAP45, or 
16 hpi for GST-PfMTIP and GST-PfGAP50. The presence of the protein of interest in the soluble fraction (S) and/or pellet (P) was 
detected by SDS-PAGE and WB with anti-GST. M: Molecular weight marker in kDa (Sigma).The WB membranes located under each 
gel correspond to exactly the same order of the gel electrophoresis lanes. 
Figure 3. SDS-PAGE analysis of temperature effect on the solubility of GST-PfMyoA and GST-PfGAP50.
The Escherichia coli cultures (strain pG-KJE8) expressing GST-PfMyoA or GST-PfGAP50 were grown at 30°C and harvested at 2 
hours post induction (hpi) in the case of GST-PfMyoA and at 16 hpi for GST-PfGAP50. The presence of the protein of interest was 
detected in the soluble fraction (S) and/or the insoluble pellet (P) by SDS-PAGE and WB with anti-GST. M: Molecular weight marker in 
kDa (Sigma).The WB membranes located under each gel correspond to exactly the same order as the gel electrophoresis lanes. 
GST-PfGAP50
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PfGAP45 was detected in the cytosolic extract, it 
was not purified by affinity with glutathione-agarose 
resin and had to be excised from acrylamide gels. 
Seven milligrams of GST-PfMTIP were obtained, 
whereas 1 mg was recovered for GST-PfGAP45.
GST-PfMyoA and GST-PfGAP50 were solubilized 
from inclusion bodies with guanidinium hydro-
chloride (8 M) and analyzed by SDS-PAGE. GST-
PfMyoA, unlike GST-PfGAP50, presented several 
contaminating proteins; therefore, it was necessary 
to extract it from acrylamide gels. Approximately 3.2 
mg of GST-PfGAP50 was recovered, whereas 800 
µg of GST-PfMyoA was recovered. Once purified, 
all of the proteins were confirmed by WB with anti-
GST (figure 4).
Immunoblotting
The MTIP (∼32 kDa), GAP50 (∼45 kDa), GAP45 
(∼50 kDa) and PfMyoA (∼90 kDa) proteins were 
identified in immunoblots of parasite protein extracts 
by the antibodies raised against GST-PfMTIP, 
GST-PfGAP50, GST-PfGAP45 and GST-PfMyoA 
respectively (figure 5).
Discussion
The expression of P. falciparum proteins in heter-
ologous systems typically results in a lack of 
expression or in insoluble expression. This problem 
was highlighted by a large-scale study where 1,000 
P. falciparum open reading frames were selected 
for expression in E. coli (16). Of these ORFs, only 
30% were expressed and only 6.3% of the resulting 
proteins were soluble. Higher molecular weight 
and protein disorder were negatively correlated 
with expression, hydrophobicity did not correlate 
with either expression or solubility, and pI was the 
only one factor associated with both expression 
and solubility. Notably, the high A/T content and 
the codon usage of P. falciparum, both usually 
correlated with lack of expression, did not affect 
significantly either the expression or solubility (16).
Later, Vedadi, et al. (17) selected 1,008 apicomplexan 
genes to be expressed in codon-enhanced E. 
coli strains. These genes were selected using P. 
falciparum as a model and looking for orthologous 
genes from P. vivax, P. yoelii, P. berghei, P. 
knowlesi, Toxoplasma gondii and Cryptosporidium 
parvum. Of these 1,008 genes, 304 (30.2%) were 
produced as soluble proteins, and when the seven 
genomes were analyzed as a “super Apicomplexan 
genome”, 229 (49%) out of the 468 target genes 
were produced as soluble proteins. Vedadi, et al. 
(17) found that protein size, A/T content or pI do 
not have any impact in the soluble expression 
and concluded that E. coli is in effect a suitable 
expression system for Apicomplexan proteins, 
including those from Plasmodium.
The present study evaluated the expression of 
four proteins from P. falciparum in three different 
strains of E. coli: TOP10, CodonPlus and pG-KJE8. 
TOP10 is a strain that allows for stable replication 
and a high copy number of plasmids; the other two 
strains are used extensively in protein expression 
and not only have a decreased protease activ-
ity but also facilitate translation (CodonPlus) or 
protein folding (pG-KJE8). By using this approach, 
the four recombinant proteins were successfully 
expressed (figure 1). GST-PfMyoA and GST-
PfGAP50 proteins were detected in SDS-PAGE and 
immunoblotting experiments about the expected 
sizes. On the other hand, GST-PfMTIP and 
Figure 4. SDS-PAGE and Western blot of the four purified recombinant proteins.
The purified proteins were subjected to SDS-PAGE in A and WB in B. The primary antibody used was a polyclonal anti-GST 
antibody (Sigma).
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GST-PfGAP45 migrated with apparent molecular 
masses of ∼55 kDa and ∼60 kDa, although they 
were predicted to encode proteins of ∼50 kDa 
(figure 4). This behavior can be explained by their 
content of acidic amino acids, whose interactions 
with SDS have been reported to slow down the 
rate of migration (18-20). 
In fact, GST-PfMTIP and GST-PfGAP45 exhibited 
the highest contents of acidic amino acids (18% 
and 21%), the lowest pI values (4.71 and 4.83) and 
the most negative charge (-25 and -26). In contrast, 
the charge and pI values were estimated at -4.5 / 
5.67 for GST-PfMyoA and 1.5 / 6.33 for GST-
PfGAP50. In spite of their anomalous migration, the 
GST-PfMTIP and GST-PfGAP45 identity was vali-
dated by sequencing the recombinant plasmids, 
and because the antibodies raised against these 
two recombinant proteins recognized their target 
proteins on P. falciparum extracts. The PfMyoA, 
MTIP, GAP45 and GAP50 proteins have theoretical 
masses of ∼92, ∼23.5, ∼23.6 and ∼45 kDa, 
respectively, and they were detected at ∼90, ∼32, 
∼50 and ∼45 kDa in WB assays using protein 
extracts of P. falciparum (3D7 strain) (figure 5). 
The anomalous migration of MTIP and GAP45 
was expected since both proteins typically run at 
molecular weights greater than would be predicted 
by their sequence. This phenomenon has been 
extensively reported and thought to result from 
post-translational modifications of the proteins 
(21,22). The GST-PfMyoA, GST-PfGAP45 and 
GST-PfGAP50 proteins were expressed in all 
three strains of E. coli, GST-PfMTIP could only be 
expressed by one strain (CodonPlus), and among 
the three strains tested, CodonPlus showed the 
most efficient expression for three of the four 
recombinant proteins (GST-PfMTIP, GST-PfGAP45, 
and GST-PfGAP50). 
This CodonPlus strain has a plasmid that contains 
extra copies of the argU, ileY, and leuW genes that 
code for tRNA with specific codons for arginine 
(AGA/AGG), isoleucine (AUA), and leucine (CUA) 
that are rare in E. coli. Since in P. falciparum the 
AGA and AUA codons are used 6.6-fold and 10-fold 
more often than in E. coli, the co-expression of this 
plasmid provides the bacteria with a supplement of 
specific tRNAs for the codons of the parasite. In 
fact, an analysis of the cloned sequences revealed 
that AGA is the most used codon for arginine and 
AUA/AUU are the most used codons for isoleucine 
(table 2). These differences in codon usage can 
explain why the expression of the GST-PfMTIP, 
GST-PfGAP45, and GST-PfGAP50 proteins in the 
CodonPlus strain is increased compared with the 
expression in the TOP10 and pG-KJE8 strains, 
which only have basal levels of these tRNAs. These 
results are consistent with what has been reported 
in other studies (23,24).
However, in the case of GST-PfMyoA, a significant 
increase in expression in the CodonPlus strain was 
not observed. Carstens (25) has proposed that 
there may be low or no expression if the frequency 
of at least one type of rare codon in the bacterium 
is ≥3% in the protein to be expressed. For GST-
PfMyoA, three rare codons, AGG, AGA and AUA, 
were found, and they reached frequencies of 0.8, 
2.8 and 4.4%, respectively (table 2). Carstens (25) 
also suggested that the consecutive presence of 
rare codons is the most important factor affecting 
the expression of a heterologous protein in E. 
Figure 5. Immunoblot on protein extracts of Plasmodium falciparum to detect PfMTIP, PfGAP50, PfGAP45 and PfMyoA.
Protein extracts from 3D7 strain of Plasmodium falciparum were subjected to denaturing electrophoresis and transferred onto PVDF 
or nitrocellulose membranes. Membranes were probed with the anti-MTIP, anti-GAP50, anti-GAP45 and anti-MyoA antibodies 
raised against the GST-PfMTIP, GST-PfGAP50, GST- PfGAP45 and GST-PfMyoA recombinant proteins, respectively.
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coli. In GST-PfMyoA, three cases were found: two 
doublets (AUAAGA) and a triplet (AUAAUAAGA); 
in GST-PfGAP45, a single case was found (the 
doublet AGAAGA) and in GST-PfGAP50 and 
GST-PfMTIP, no cases were found. Goldman, 
et al. (26) reported that the effect of successive 
rare codons on expression is more noticeable 
when they are located near the amino terminus 
of the protein, especially when the codons code 
for arginine. Chen, et al. (27) explain that this 
result occurs because of instability in the protein 
synthesis machinery near the beginning of the 
message. Upon analyzing the four sequences, 
only GST-PfMyoA (250 amino acids) presented 
this condition at codons 14-15 and 36-37. All of 
the above characteristics of the GST-PfMyoA 
sequence can explain why despite the use of three 
genetically different strains, an important increase 
in its production was not achieved.
GST-PfMyoA and GST-PfGAP50 were produced as 
protein aggregates, while GST-PfMTIP and GST-
PfGAP45 were found in the cytoplasmic fraction. The 
results show that, for these proteins, A/T content, 
size protein and pI do not have noticeable effect on 
expression or solubility. Although the CodonPlus 
strain promotes expression of certain proteins of 
P. falciparum, the insolubility of the recombinant 
protein has been reported. Because translation is 
more efficient, the set of available chaperones to 
assist in protein folding becomes saturated and 
this may cause the accumulation and aggregation 
of misfolded proteins in the cytoplasm (28). The 
E. coli pG-KJE8 strain overexpresses both multi-
component chaperone complexes present in E. coli: 
the gro proteins EL (60 kDa) and ES (10 kDa), and 
the KJE complex, which is formed by chaperones 
dnaK, dnaJ and grpE (29). In this way, if there is poor 
folding because of the saturation of the chaperone 
system itself, the presence of additional molecules 
will facilitate the proper folding of the protein, and it 
would be reflected in an increase in solubility (30-
32). In our case, the evaluation of the solubility of 
the recombinant proteins produced in CodonPlus 
and pG-KJE8 strains showed similar results that 
were independent of the adjusted conditions for 
expression (temperature, time of incubation and 
IPTG concentration). Thus, the use of a bacterial 
system that provides extra chaperones did not 
prevent the formation of insoluble aggregates of 
GST-PfMyoA or GST-PfGAP50, indicating that 
additional factors other than the availability of 
the folding machinery determined the solubility of 
these recombinant proteins. 
According to Wall, et al. (33), the specific role of the 
co-production of chaperones on the expression of a 
gene in E. coli is unclear and appears to be specific 
to each protein. In fact, undesirable side effects 
derived from chaperone gene co-expression, such 
as growth inhibition, proteolysis, reduced yield, 
reduced solubility or reduced specific activity, have 
been reported (34).
With respect to the purification of GST-PfGAP45, 
we suggest that the protein adopts a three-
dimensional structure that prevents free exposure 
of the GST tag, thus preventing the recombinant 
protein from interacting with the glutathione agar-
ose resin. This may explain why GST-PfGAP45 
could not be purified by affinity chromatography. 
The detection of GST-PfGAP45 with anti-GST in 
denaturing conditions allows us to state that the 
GST tag was present.
In this study, the main purpose of producing the 
four recombinant proteins was to achieve suitable 
quantities of proteins for immunizing animals and 
generating antibodies, and to obtain large quantities 
of soluble proteins in sight of future in vitro protein-
protein interaction studies. To achieve this goal, we 
used different host cells to establish the conditions 
in which the most efficient expression might be 
obtained and sought conditions that would allow us 
to express the protein in its native conformation. 
Although it was not possible to obtain all the 
proteins in soluble form and the use of denaturing 
agents for solubilization was required in two cases, 
the four proteins were obtained in high quantity.
Our results indicate that the use of genetically 
modified strains for the expression of P. falciparum 
proteins was necessary to improve the synthesis 
and achieve higher expression levels detectable 
by Coomassie blue staining, but their use did not 
necessarily have a positive effect on the solubility 
of the proteins. The CodonPlus strain favored 
the expression of three proteins, but the solubility 
varied from a completely soluble protein such as 
GST-PfMTIP to a completely insoluble protein such 
as GST-PfGAP50.
Although it is not possible to generalize about 
heterologous expression strategies, the approach 
used here led us to obtain four P. falciparum 
proteins corresponding to partial sequences of 
PfMyoA and GAP50, and the complete sequences 
of MTIP and GAP45. From 1 L of culture, we were 
able to produce and purify enough material for 
immunizing mice and for keeping a large supply 
for future uses.
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